相关实验视频

Updated: Jun 16, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

血性淋巴瘤:2024年关于诊断,风险分层和管理的更新

Andres Ramirez-Gamero¹, Humberto Martínez-Cordero², Brady E Beltrán³

¹Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

American journal of hematology

|May 20, 2024

概括

血性淋巴瘤 (PBL) 是一种侵袭性,罕见的癌症,影响B细胞. 虽然经常与免疫抑制有关,但它可能发生在健康个体中,需要先进的治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
病理学病理学病理学

背景情况:

血性淋巴瘤 (PBL) 是一种罕见的,激进的,CD20阴性淋巴瘤.
PBL与人体免疫缺陷病毒感染和免疫抑制有关,但可以影响免疫能力强的个体.

研究的目的:

提供关于等离子体淋巴瘤的全面概述,涵盖其特征,诊断,风险分层和管理.
为了突出诊断和治疗这种罕见的侵袭性淋巴瘤的挑战.

主要方法:

审查PBL的临床和病理特征.
诊断标准的分析,包括免疫组织化学和EBER和MYC等分子标记.
预后因素和当前治疗策略的评估.

主要成果:

PBL的特点是其侵略性和标准治疗的不良预后.
诊断需要高度的临床怀疑和病理确认,频繁的EBER表达和MYC重组.
年龄,晚期和高国际预测指数得分与更差的生存率有关.

结论:

血性淋巴瘤的有效管理涉及组合化疗 (例如,EPOCH) 和潜在的新药.
进一步的研究和临床试验对于改善PBL患者的治疗结果至关重要.

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.